entertainment -WSS

entertainment

author：knowledge 2025-10-01 00:48:15 - browse：891

The Food and Drug Administration’s advisory panel of pediatric experts met on Tuesday to discuss advances in artificial womb technology, which aim to save the lives of premature babies.

The goal of the meeting was to discuss measures for evaluating the safety and efficacy of an artificial womb. The group grappled with the limits of current animal data, as well as the ethical difficulties in running human trials. On Wednesday, the committee’s meeting will be closed to the public in order to protect trade secrets.

Extremely premature babies, defined as infants born at less than 28 weeks, rarely survive. About half of infants born at 23 weeks survive, according to a 2022 study in the Journal of the American Medical Association, and at 22 weeks just 10% survive. This population represents less than 2% of all premature babies, but the problem is growing; the Centers for Disease Control and Prevention reported that the preterm birth rate rose by 4% between 2020 and 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： AI models in health care face new federal disclosure requirements

WSS

Radiology is caught between AI's potential and concern for patients

After sickle

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

In new study, freeze

7 of the most gruesome medical devices in history

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

knowledge

entertainment

focus

Affirmative action in medical school literally saved lives

Artificial intelligence advances fuel industry trying to preserve loved ones after death

How to save PrEP access — and even expand it

In diabetes hearing, Sanders takes on a new foe: food makers

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Trump demands the U.S. pay no more for drugs than other countries … again

As Taiwan prepares for anti

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Supreme Court wrestles with OxyContin maker's bankruptcy deal

hotspot

HIPAA doesn't protect reproductive records from prosecutors

Leukemia patients are helped by Syndax's new type of therapy

Why sickle cell disease is getting the first CRISPR treatment

The woman behind the Dana Farber

What PEPFAR has meant on the ground in Ukraine

As Taiwan prepares for anti

focus

focus

hotspot

Wikipedia